Effect of chronic administration of progesterone on the naloxone-induced LHRH release from hypothalami of ovariectomized, estradiol-primed prepubertal rats

Life Sci. 1988;43(7):609-13. doi: 10.1016/0024-3205(88)90065-3.

Abstract

To test the hypothesis that progesterone (P) administered in a high dose and for a long duration would influence in vitro LHRH release by naloxone, silastic capsules containing P (50 mg/ml) or vehicle were implanted sc in ovariectomized, estradiol-primed (OVX+E) prepubertal rats. Following a 48 hr exposure to P, rats were sacrificed and mediobasal hypothalamic (MBH) fragments were obtained. In addition, in other OVX+E primed rats, a single injection of P (1 mg) was given sc 6 hr prior to decapitation. Naloxone or control medium were infused into superfusion chambers containing MBH fragments derived from these animals for 2 hr following a 1 hr control period. Infusion of naloxone (1 x 10(-4) M) markedly stimulated in vitro LHRH release from MBH from rats pre-exposed to P for 48 hr, whereas it was unable to do so in other groups examined. These data clearly indicate that the ability of naloxone (1 x 10(-4) M) to stimulate LHRH release is dependent on the duration of P administration.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Estradiol / pharmacology
  • Female
  • Gonadotropin-Releasing Hormone / metabolism*
  • Hypothalamus / drug effects
  • Hypothalamus / metabolism*
  • In Vitro Techniques
  • Naloxone / pharmacology*
  • Ovariectomy
  • Progesterone / administration & dosage
  • Progesterone / pharmacology*
  • Rats
  • Rats, Inbred Strains
  • Sexual Maturation

Substances

  • Gonadotropin-Releasing Hormone
  • Naloxone
  • Progesterone
  • Estradiol